DIPEXIUM PHARMACEUTICALS INC - COM (DPRX)

CUSIP: 25456J104

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
2,933,609
Share change
+1,189,457
Total reported value
$37,321,904
Price per share
$12.72
Number of holders
27
Value change
+$15,103,633
Number of buys
17
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 25456J104?
CUSIP 25456J104 identifies DPRX - DIPEXIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) as of Q2 2015

As of 30 Jun 2015, DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,933,609 shares. The largest 10 holders included KINGDON CAPITAL MANAGEMENT, L.L.C., Tourbillon Capital Partners, L.P., Broadfin Capital, LLC, Timpani Capital Management LLC, Lone Star Value Management LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, 683 Capital Management, LLC, ARDSLEY ADVISORY PARTNERS, and MILLENNIUM MANAGEMENT LLC. This page lists 27 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.